Stock Earnings

Question 1

What are Aquestive Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Aquestive Therapeutics Inc has a total asset of $101, Net loss of $-44

Question 2

What are the key financial ratios for AQST?

Accepted Answer

Aquestive Therapeutics Inc's Current ratio is 0.62, has a Net margin is -77.19, sales per share of $0.65.

Question 3

How is Aquestive Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Aquestive Therapeutics Inc largest revenue segment is Pharmaceutical, at a revenue of 57,561,000 in the most earnings release.For geography, United States is the primary market for Aquestive Therapeutics Inc, at a revenue of 39,930,000.

Question 4

Is Aquestive Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Aquestive Therapeutics Inc has a net loss of $-44

Question 5

Does Aquestive Therapeutics Inc have any liabilities?

Accepted Answer

yes, Aquestive Therapeutics Inc has liability of 161

Question 6

How many outstanding shares for Aquestive Therapeutics Inc?

Accepted Answer

Aquestive Therapeutics Inc has a total outstanding shares of 91.41

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	43	57	50	47	50	45
Revenue Growth (YoY)	-26%	14%	6%	-6%	11%	-13%
Cost of Revenue	17	17	20	19	14	12
Gross Profit	26	39	29	28	35	32
Selling, General & Admin	63	50	31	52	53	55
Research & Development	18	20	13	17	17	19
Operating Expenses	81	70	44	70	70	75
Other Non Operating Income (Expenses)	-5	-5	-1	--	--	--
Pretax Income	-68	-44	-7	-54	-70	-55
Income Tax Expense	0	0	0	0	0	0
Net Income	-68	-44	-7	-54	-70	-55
Net Income Growth	94%	529%	-87%	-23%	27%	-17%
Shares Outstanding (Diluted)	110.58	86.72	61.25	48.73	38.08	33.65
Shares Change (YoY)	22%	42%	26%	28%	13%	33%
EPS (Diluted)	-0.62	-0.5	-0.12	-1.12	-1.85	-1.66
EPS Growth	59%	296%	-89%	-39%	11%	-36%
Free Cash Flow	-51	-35	-7	-12	-33	-45
Free Cash Flow Per Share	-0.46	-0.4	-0.11	-0.24	-0.86	-1.33
Gross Margin	60.46%	68.42%	57.99%	59.57%	70%	71.11%
Operating Margin	-130.23%	-52.63%	-30%	-89.36%	-68%	-93.33%
Profit Margin	-158.13%	-77.19%	-14%	-114.89%	-140%	-122.22%
Free Cash Flow Margin	-118.6%	-61.4%	-14%	-25.53%	-66%	-100%
EBITDA	-56	-30	-14	-40	-32	-39
EBITDA Margin	-130.23%	-52.63%	-28%	-85.1%	-64%	-86.66%
D&A For EBITDA	0	0	1	2	2	3
EBIT	-56	-30	-15	-42	-34	-42
EBIT Margin	-130.23%	-52.63%	-30%	-89.36%	-68%	-93.33%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Aquestive Therapeutics Inc (AQST) Price

AQST Stock Price Chart

AQST Income

Follow-Up Questions